- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03818711
Communication and Coping for Mothers of Adolescents With Type 1 Diabetes (T1D)
Communication and Coping: Addressing Mothers' Needs to Improve Outcomes in Adolescents With T1D
Mothers of adolescents with type 1 diabetes experience high levels of depressive symptoms, which impair their ability to monitor and manage diabetes treatment effectively. Further, maternal depressive symptoms are one of the strongest predictors of negative outcomes in adolescents, including deteriorating glycemic control, problems with adherence, poorer quality of life, and greater risk for depression. Given that adolescents are a high-risk population for suboptimal glycemic control - with only 17% meeting treatment goals - there is a critical need for novel interventions to improve outcomes in adolescents with T1D. Yet, previous behavioral interventions for youth with diabetes have had only modest effects on glycemic control, and none have directly targeted maternal depressive symptoms.
Building on effective interventions to treat depression in adults, and our own pilot work in this population, the proposed study will use a rigorous approach to evaluate the efficacy of a cognitive-behavioral intervention for mothers of adolescents with type 1 diabetes to promote the use of adaptive coping strategies and positive parenting practices. The aims of this study are to: 1) evaluate the effects of the Communication & Coping intervention on diabetes-related outcomes; 2) evaluate the effects of the Communication & Coping intervention on psychosocial outcomes; and 3) explore the differential impact of the intervention across demographic factors. Mothers who are randomized to the Communication & Coping Intervention will receive individual cognitive-behavioral therapy sessions by phone, as well as access to a Facebook group to augment the material covered in calls and provide social support. Mothers randomized to the Attention Control condition will receive educational materials and phone check-ins, as well as a Facebook group with educational posts. Adolescents and their mothers will be assessed at baseline and again post-intervention, at 3 months, 6 months, and 12 months.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mothers of adolescents with type 1 diabetes experience high levels of depressive symptoms, which impair their ability to monitor and manage diabetes treatment effectively. The regimen recommended for type 1 diabetes is complex and demanding, and caregivers - especially mothers - experience stress related to the burden of treatment management. This stress is associated with increased risk for psychosocial problems in caregivers, with rates of clinically significant depressive symptoms evident in up to 61% of parents. Further, maternal depressive symptoms are one of the strongest predictors of negative outcomes in adolescents, including deteriorating glycemic control, problems with adherence, poorer quality of life, and greater risk for depression. Given that adolescents are a high-risk population for suboptimal glycemic control - with only 17% meeting treatment goals - there is a critical need for novel interventions to improve outcomes in adolescents with T1D. Yet, previous behavioral interventions for youth with diabetes have had only modest effects on glycemic control, and none have directly targeted maternal depressive symptoms. Responding to the American Diabetes Association's call to address the psychosocial needs of people with diabetes and their family members, the proposed project has the potential to improve outcomes in both adolescents with type 1 diabetes and their mothers.
Building on effective interventions to treat depression in adults, and our own pilot work in this population, the proposed study will use a rigorous approach to evaluate the efficacy of a cognitive-behavioral intervention for mothers of adolescents with type 1 diabetes to promote the use of adaptive coping strategies and positive parenting practices. The aims of this study are to: 1) evaluate the effects of the Communication & Coping intervention on diabetes-related outcomes; 2) evaluate the effects of the Communication & Coping intervention on psychosocial outcomes; and 3) explore the differential impact of the intervention across demographic factors. Mothers who are randomized to the Communication & Coping Intervention will receive individual cognitive-behavioral therapy sessions by phone, as well as access to a Facebook group to augment the material covered in calls and provide social support. Mothers randomized to the Attention Control condition will receive educational materials and phone check-ins, as well as a Facebook group with educational posts. Adolescents and their mothers will be assessed at baseline and again post-intervention, at 3 months, 6 months, and 12 months. We hypothesize that the adolescents of mothers who receive the intervention will demonstrate improvements in diabetes outcomes (i.e., glycemic control, adherence), as well as psychosocial outcomes (i.e., improved quality of life, fewer depressive symptoms) compared to those in the attention control condition. This approach is innovative by targeting maternal depressive symptoms and the quality of parental involvement in mothers of adolescents with type 1 diabetes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female caregiver of an adolescent with type 1 diabetes
- Adolescent age 11-17
- Adolescent diagnosed with type 1 diabetes for at least 12 months
- Caregiver reports mild to moderate depressive symptoms (PHQ-9 score of 5-19) OR OR caregiver reports diabetes distress (Parent/Teen Relationship Distress Subscale score of 2 or higher)
- English speaking
Exclusion Criteria:
- Caregiver reports minimal depressive symptoms (PHQ-9 score less than 5)
- Caregiver reports severe depressive symptoms (PHQ-9 score 20 or higher)
- Caregiver reports history of severe psychopathology (bipolar disorder or schizophrenia)
- Caregiver reports that adolescent has history of severe psychopathology (bipolar disorder or schizophrenia)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Communication & Coping Intervention
A cognitive behavioral intervention for mothers of adolescents with type 1 diabetes to improve coping and the quality of parental involvement.
|
Mothers receive a treatment manual and participate in individual phone calls aimed at reducing depressive symptoms and improving the quality of parental involvement.
A concurrent secret Facebook group will have daily posts to reinforce concepts.
|
Active Comparator: Education & Check Ins
The comparison group receives educational materials on diabetes management and phone calls, as well as access to a secret Facebook group with daily posts on diabetes management.
|
Mothers receive educational materials and participate in individual phone calls related to these materials.
A concurrent secret Facebook group will have daily educational posts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic control (A1C)
Time Frame: 3 months
|
Hemoglobin A1c measured as part of clinic visit
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal depressive symptoms
Time Frame: 3 months
|
Depressive symptoms measured using the Patient Health Questionnaire (PHQ-9), a 9-item measure.
Scores range from 0-27; scores 0-4 indicate minimal depression, scores 5-9 indicate mild depression, scores 10-14 indicate moderate depression, scores 15-19 indicate moderately severe depression, and scores 20-27 indicate severe depression.
|
3 months
|
Mothers' Diabetes Distress
Time Frame: 3 months
|
Parent Diabetes Distress Scale (PDDS) is a measure consisting of 20 items to rate diabetes-related stress for parents of children with type 1 diabetes.
A mean total score will be calculated, ranging from 0-5, with higher scores indicating greater distress.
|
3 months
|
Adolescent psychosocial functioning - parent report
Time Frame: 3 months
|
Child Behavior Checklist (CBCL) is a parent-reported measure of behavior problems in children ages 6-18.
The Internalizing and Externalizing broad-band scales will be used in analyses.
T scores are based on age and gender, and scores of 70 or higher indicate clinically significant problems.
|
3 months
|
Adolescent psychosocial functioning - self report
Time Frame: 3 months
|
Youth Self Report (YSR) is a measure of self-reported behavior problems in youth ages 11-18.
The Internalizing and Externalizing broad-band scales will be used in analyses.
T scores are based on age and gender, and scores of 70 or higher indicate clinically significant problems.
|
3 months
|
Adolescent quality of life
Time Frame: 3 months
|
Pediatric Quality of Life (PedsQL) is a self-reported measure of diabetes-related quality of life in youth.
Scaled scores range from 0-100, with higher scores indicating better quality of life.
|
3 months
|
Diabetes-related family conflict - parent report
Time Frame: 3 months
|
Diabetes-specific family conflict was measured with the Revised Diabetes Family Conflict Scale (DFCS), which consists of 19 items regarding how much adolescents and parents argue about diabetes management.
Scores range from 19-57, with higher scores indicating higher levels of conflict.
|
3 months
|
Diabetes-related family conflict - adolescent report
Time Frame: 3 months
|
Diabetes-specific family conflict will be measured with the Revised Diabetes Family Conflict Scale (DFCS), which consists of 19 items regarding how much adolescents and parents argue about diabetes management.
Scores range from 19-57, with higher scores indicating higher levels of conflict.
|
3 months
|
Maternal coping
Time Frame: 3 months
|
Responses to stress questionnaire - type 1 diabetes - (RSQ) is a measure of coping with diabetes-related stress.
Ratio scores range from .00 to 1.00, and higher scores indicate higher relative use of coping.
|
3 months
|
Mothers' Social Support
Time Frame: 3 months
|
Multidimensional Scale of Perceived Social Support (MSPSS) is a 12-item scale of social support from family, friends and significant others.
A mean total score will be calculated, ranging from 1-7, with higher scores indicating greater perceived social support.
|
3 months
|
Maternal Symptoms of Anxiety
Time Frame: 3 months
|
Generalized Anxiety Disorder Scale - 7 (GADS-7) consists of 7 items measuring symptoms of anxiety.
Scores range from 0-21, and scores of 10 or higher are considered clinically meaningful.
|
3 months
|
Adolescent Diabetes Distress
Time Frame: 3 months
|
Problem Area in Diabetes - Teen (PAID-T) consists of 14 items measuring adolescents' diabetes distress.
Scores range from 14-84, and scores of 44 or higher are considered clinically meaningful.
|
3 months
|
Diabetes Knowledge
Time Frame: 3 months
|
Revised Brief Diabetes Knowledge Test is a measure of parents' diabetes knowledge.
It consists of 23 items that ask about diabetes-related information.
Scores range from 0-23, with higher scores indicating greater diabetes knowledge.
|
3 months
|
Parental Involvement
Time Frame: 3 months
|
Collaborative Parent Involvement (CPI) is a 12-item scale completed by adolescents to assess parental involvement in diabetes care.
Mean scores range from 1-5, with higher scores indicating more collaborative parental involvement.
|
3 months
|
Adolescent Adherence
Time Frame: 3 months
|
Self Care Inventory (SCI) is a 14-item measure completed by adolescents to assess their diabetes self-management behaviors.
Mean scores range from 1-5, and higher scores indicate better adherence to the diabetes regimen.
|
3 months
|
Quality of Parental Involvement
Time Frame: 6 months
|
Mothers and adolescents will participate in a videotaped conversation, which will be scored by objective raters using the Iowa Family Interaction Rating Scales (IFIRS).
The collaborative parenting composite includes the following codes: Communication; Positive Reinforcement; and Child Centered.
Scores on the collaborative parenting composite range from 3-27, with higher scores indicating higher levels of collaborative parenting.
The overinvolved/intrusive parenting composite includes: Parental Influence; Intrusiveness; and Lecture/Moralize.
Scores on the overinvolved scale range from 3-27, with higher scores indicating higher levels of observed behavior.
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sarah Jaser, PhD, Vanderbilt University Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 171940
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Hoffmann-La RocheRoche DiagnosticsCompletedDiabetes Mellitus Type 2, Diabetes Mellitus Type 1Germany
Clinical Trials on Communication & Coping Intervention
-
US Department of Veterans AffairsNational Cancer Institute (NCI)CompletedNeoplasms | AgingUnited States
-
Vanderbilt UniversityNationwide Children's HospitalTerminatedPediatric CancerUnited States
-
Boston University Charles River CampusNational Cancer Institute (NCI)CompletedChildhood Cancer | Posttraumatic Stress Disorder | Pediatric Cancer | SiblingsUnited States
-
Bart CJM FauserCompleted
-
RANDUniversity of Southern California; University of Massachusetts, Boston; APLA...RecruitingHealth Care Utilization | Discrimination, SocialUnited States
-
Carnegie Mellon UniversityJuvenile Diabetes Research FoundationRecruitingDiabetes Mellitus, Type 1United States
-
RANDBienestar Human Services, Inc.Recruiting
-
Centers for Disease Control and PreventionUniversity of GeorgiaCompletedHIV Infections | Sexually Transmitted Diseases | PregnancyUnited States
-
Clinical Research Centre, MalaysiaMinistry of Health, Malaysia; National University of Malaysia; Institute for...Not yet recruitingBreast Neoplasm FemaleMalaysia
-
Duke UniversityCompletedImproved Communication Between Clinician and PatientUnited States